SRx Health Solutions, Inc. 8-K

What Happened

• SRx Health Solutions, Inc. (SRXH) filed an 8-K on January 8, 2026 (Item 3.01) reporting that the NYSE American accepted the company’s plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
• The acceptance continues SRx’s listing under an extension with a targeted completion date of July 14, 2026. NYSE had previously notified the company on October 14, 2025 that it was below the required continued listing standards.

Key Details

• NYSE found SRx noncompliant because it reported stockholders’ equity of ($45.9) million as of June 30, 2025.
• The company also reported losses from continuing operations and/or net losses in 3 of its 4 most recent fiscal years ended December 31, 2024.
• The Plan Period runs through July 14, 2026; SRx will provide quarterly updates to NYSE American on progress.
• SRx issued a press release on January 8, 2026 announcing these developments (Exhibit 99.1).

Why It Matters

• The NYSE acceptance avoids immediate delisting but requires SRx to meet specific remediation goals by July 14, 2026 to maintain its listing.
• Negative stockholders’ equity and recurring losses are material financial concerns for investors; the company’s ability to restore required equity levels and improve results will be key.
• Investors should monitor the company’s quarterly updates and subsequent SEC filings for progress on the compliance plan and any changes to financial condition or strategy.